CN114317636A - Preparation method of oligosaccharide - Google Patents
Preparation method of oligosaccharide Download PDFInfo
- Publication number
- CN114317636A CN114317636A CN202111636211.0A CN202111636211A CN114317636A CN 114317636 A CN114317636 A CN 114317636A CN 202111636211 A CN202111636211 A CN 202111636211A CN 114317636 A CN114317636 A CN 114317636A
- Authority
- CN
- China
- Prior art keywords
- gly
- beta
- glucanase
- val
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 35
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 101710130006 Beta-glucanase Proteins 0.000 claims abstract description 67
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 37
- 229920002558 Curdlan Polymers 0.000 claims abstract description 36
- 239000001879 Curdlan Substances 0.000 claims abstract description 36
- 229940078035 curdlan Drugs 0.000 claims abstract description 36
- 235000019316 curdlan Nutrition 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 18
- 229920001503 Glucan Polymers 0.000 claims abstract description 17
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 15
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 14
- 150000001413 amino acids Chemical group 0.000 claims description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 4
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims description 4
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 31
- 230000007062 hydrolysis Effects 0.000 abstract description 15
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 12
- 239000000413 hydrolysate Substances 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 2
- 238000005265 energy consumption Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 description 19
- 102000004190 Enzymes Human genes 0.000 description 19
- 229940088598 enzyme Drugs 0.000 description 19
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 241000269331 Ambystoma Species 0.000 description 10
- IFBHRQDFSNCLOZ-UHFFFAOYSA-N 2-(hydroxymethyl)-6-(4-nitrophenoxy)oxane-3,4,5-triol Chemical compound OC1C(O)C(O)C(CO)OC1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-UHFFFAOYSA-N 0.000 description 7
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 6
- 108010047495 alanylglycine Proteins 0.000 description 6
- 108010087924 alanylproline Proteins 0.000 description 6
- 108010050848 glycylleucine Proteins 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 241000205573 Jeffersonia Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000004816 latex Substances 0.000 description 5
- 229920000126 latex Polymers 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- CSAHOYQKNHGDHX-ACZMJKKPSA-N Ala-Gln-Asn Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CSAHOYQKNHGDHX-ACZMJKKPSA-N 0.000 description 4
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 4
- 108010090461 DFG peptide Proteins 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- TZOVVRJYUDETQG-RCOVLWMOSA-N Gly-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CN TZOVVRJYUDETQG-RCOVLWMOSA-N 0.000 description 4
- QUBVFEANYYWBTM-VEVYYDQMSA-N Pro-Thr-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O QUBVFEANYYWBTM-VEVYYDQMSA-N 0.000 description 4
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 4
- 239000007979 citrate buffer Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 2
- YEJQWBFDKKTPNO-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-methylbutanoic acid Chemical compound CC(C)C(N)C(=O)N1CCCC1C(=O)NCC(=O)NC(C(C)C)C(O)=O YEJQWBFDKKTPNO-UHFFFAOYSA-N 0.000 description 2
- RLMISHABBKUNFO-WHFBIAKZSA-N Ala-Ala-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O RLMISHABBKUNFO-WHFBIAKZSA-N 0.000 description 2
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 2
- JAMAWBXXKFGFGX-KZVJFYERSA-N Ala-Arg-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JAMAWBXXKFGFGX-KZVJFYERSA-N 0.000 description 2
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 2
- VBRDBGCROKWTPV-XHNCKOQMSA-N Ala-Glu-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N VBRDBGCROKWTPV-XHNCKOQMSA-N 0.000 description 2
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 2
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 2
- VRTOMXFZHGWHIJ-KZVJFYERSA-N Ala-Thr-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VRTOMXFZHGWHIJ-KZVJFYERSA-N 0.000 description 2
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 2
- KUFVXLQLDHJVOG-SHGPDSBTSA-N Ala-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C)N)O KUFVXLQLDHJVOG-SHGPDSBTSA-N 0.000 description 2
- RIPMDCIXRYWXSH-KNXALSJPSA-N Ala-Trp-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N3CCC[C@@H]3C(=O)O)N RIPMDCIXRYWXSH-KNXALSJPSA-N 0.000 description 2
- JNJHNBXBGNJESC-KKXDTOCCSA-N Ala-Tyr-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JNJHNBXBGNJESC-KKXDTOCCSA-N 0.000 description 2
- MUGAESARFRGOTQ-IGNZVWTISA-N Ala-Tyr-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N MUGAESARFRGOTQ-IGNZVWTISA-N 0.000 description 2
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 2
- BHSYMWWMVRPCPA-CYDGBPFRSA-N Arg-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N BHSYMWWMVRPCPA-CYDGBPFRSA-N 0.000 description 2
- RWCLSUOSKWTXLA-FXQIFTODSA-N Arg-Asp-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RWCLSUOSKWTXLA-FXQIFTODSA-N 0.000 description 2
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 2
- KRQSPVKUISQQFS-FJXKBIBVSA-N Arg-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N KRQSPVKUISQQFS-FJXKBIBVSA-N 0.000 description 2
- FRMQITGHXMUNDF-GMOBBJLQSA-N Arg-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N FRMQITGHXMUNDF-GMOBBJLQSA-N 0.000 description 2
- FFEUXEAKYRCACT-PEDHHIEDSA-N Arg-Ile-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(O)=O FFEUXEAKYRCACT-PEDHHIEDSA-N 0.000 description 2
- PYZPXCZNQSEHDT-GUBZILKMSA-N Arg-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N PYZPXCZNQSEHDT-GUBZILKMSA-N 0.000 description 2
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 2
- POZKLUIXMHIULG-FDARSICLSA-N Arg-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)N POZKLUIXMHIULG-FDARSICLSA-N 0.000 description 2
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 2
- YNDLOUMBVDVALC-ZLUOBGJFSA-N Asn-Ala-Ala Chemical compound C[C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC(=O)N)N YNDLOUMBVDVALC-ZLUOBGJFSA-N 0.000 description 2
- AYKKKGFJXIDYLX-ACZMJKKPSA-N Asn-Gln-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O AYKKKGFJXIDYLX-ACZMJKKPSA-N 0.000 description 2
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 2
- IICZCLFBILYRCU-WHFBIAKZSA-N Asn-Gly-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IICZCLFBILYRCU-WHFBIAKZSA-N 0.000 description 2
- VXLBDJWTONZHJN-YUMQZZPRSA-N Asn-His-Gly Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N VXLBDJWTONZHJN-YUMQZZPRSA-N 0.000 description 2
- WIDVAWAQBRAKTI-YUMQZZPRSA-N Asn-Leu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O WIDVAWAQBRAKTI-YUMQZZPRSA-N 0.000 description 2
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 2
- PIABYSIYPGLLDQ-XVSYOHENSA-N Asn-Thr-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PIABYSIYPGLLDQ-XVSYOHENSA-N 0.000 description 2
- PBVLJOIPOGUQQP-CIUDSAMLSA-N Asp-Ala-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O PBVLJOIPOGUQQP-CIUDSAMLSA-N 0.000 description 2
- HMQDRBKQMLRCCG-GMOBBJLQSA-N Asp-Arg-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HMQDRBKQMLRCCG-GMOBBJLQSA-N 0.000 description 2
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 2
- KLYPOCBLKMPBIQ-GHCJXIJMSA-N Asp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N KLYPOCBLKMPBIQ-GHCJXIJMSA-N 0.000 description 2
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 2
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- KWLMLNHADZIJIS-CIUDSAMLSA-N Gln-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N KWLMLNHADZIJIS-CIUDSAMLSA-N 0.000 description 2
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 2
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 2
- YPFFHGRJCUBXPX-NHCYSSNCSA-N Gln-Pro-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(O)=O YPFFHGRJCUBXPX-NHCYSSNCSA-N 0.000 description 2
- UTOQQOMEJDPDMX-ACZMJKKPSA-N Gln-Ser-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O UTOQQOMEJDPDMX-ACZMJKKPSA-N 0.000 description 2
- RWQCWSGOOOEGPB-FXQIFTODSA-N Gln-Ser-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O RWQCWSGOOOEGPB-FXQIFTODSA-N 0.000 description 2
- JKDBRTNMYXYLHO-JYJNAYRXSA-N Gln-Tyr-Leu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 JKDBRTNMYXYLHO-JYJNAYRXSA-N 0.000 description 2
- SOEXCCGNHQBFPV-DLOVCJGASA-N Gln-Val-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SOEXCCGNHQBFPV-DLOVCJGASA-N 0.000 description 2
- VPKBCVUDBNINAH-GARJFASQSA-N Glu-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N)C(=O)O VPKBCVUDBNINAH-GARJFASQSA-N 0.000 description 2
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 2
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 2
- VSVZIEVNUYDAFR-YUMQZZPRSA-N Gly-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN VSVZIEVNUYDAFR-YUMQZZPRSA-N 0.000 description 2
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 2
- JXYMPBCYRKWJEE-BQBZGAKWSA-N Gly-Arg-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O JXYMPBCYRKWJEE-BQBZGAKWSA-N 0.000 description 2
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 2
- JVWPPCWUDRJGAE-YUMQZZPRSA-N Gly-Asn-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JVWPPCWUDRJGAE-YUMQZZPRSA-N 0.000 description 2
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 2
- FZQLXNIMCPJVJE-YUMQZZPRSA-N Gly-Asp-Leu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FZQLXNIMCPJVJE-YUMQZZPRSA-N 0.000 description 2
- CQZDZKRHFWJXDF-WDSKDSINSA-N Gly-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CN CQZDZKRHFWJXDF-WDSKDSINSA-N 0.000 description 2
- ADZGCWWDPFDHCY-ZETCQYMHSA-N Gly-His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 ADZGCWWDPFDHCY-ZETCQYMHSA-N 0.000 description 2
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 2
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 2
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 2
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 2
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 2
- SCJJPCQUJYPHRZ-BQBZGAKWSA-N Gly-Pro-Asn Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O SCJJPCQUJYPHRZ-BQBZGAKWSA-N 0.000 description 2
- OCPPBNKYGYSLOE-IUCAKERBSA-N Gly-Pro-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN OCPPBNKYGYSLOE-IUCAKERBSA-N 0.000 description 2
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 2
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 2
- NIOPEYHPOBWLQO-KBPBESRZSA-N Gly-Trp-Glu Chemical compound NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(O)=O NIOPEYHPOBWLQO-KBPBESRZSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- VSLXGYMEHVAJBH-DLOVCJGASA-N His-Ala-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O VSLXGYMEHVAJBH-DLOVCJGASA-N 0.000 description 2
- FRDFAWHTPDKRHG-ULQDDVLXSA-N His-Tyr-Arg Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CN=CN1 FRDFAWHTPDKRHG-ULQDDVLXSA-N 0.000 description 2
- HIJIJPFILYPTFR-ACRUOGEOSA-N His-Tyr-Tyr Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O HIJIJPFILYPTFR-ACRUOGEOSA-N 0.000 description 2
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 2
- WZPIKDWQVRTATP-SYWGBEHUSA-N Ile-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 WZPIKDWQVRTATP-SYWGBEHUSA-N 0.000 description 2
- IIXDMJNYALIKGP-DJFWLOJKSA-N Ile-Asn-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N IIXDMJNYALIKGP-DJFWLOJKSA-N 0.000 description 2
- NPROWIBAWYMPAZ-GUDRVLHUSA-N Ile-Asp-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N NPROWIBAWYMPAZ-GUDRVLHUSA-N 0.000 description 2
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 2
- IGJWJGIHUFQANP-LAEOZQHASA-N Ile-Gly-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N IGJWJGIHUFQANP-LAEOZQHASA-N 0.000 description 2
- RIVKTKFVWXRNSJ-GRLWGSQLSA-N Ile-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N RIVKTKFVWXRNSJ-GRLWGSQLSA-N 0.000 description 2
- CIDLJWVDMNDKPT-FIRPJDEBSA-N Ile-Phe-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N CIDLJWVDMNDKPT-FIRPJDEBSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- WSGXUIQTEZDVHJ-GARJFASQSA-N Leu-Ala-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O WSGXUIQTEZDVHJ-GARJFASQSA-N 0.000 description 2
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 2
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 2
- VPKIQULSKFVCSM-SRVKXCTJSA-N Leu-Gln-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPKIQULSKFVCSM-SRVKXCTJSA-N 0.000 description 2
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 2
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 2
- HGFGEMSVBMCFKK-MNXVOIDGSA-N Leu-Ile-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HGFGEMSVBMCFKK-MNXVOIDGSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 2
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 2
- GKFNXYMAMKJSKD-NHCYSSNCSA-N Lys-Asp-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GKFNXYMAMKJSKD-NHCYSSNCSA-N 0.000 description 2
- MRWXLRGAFDOILG-DCAQKATOSA-N Lys-Gln-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MRWXLRGAFDOILG-DCAQKATOSA-N 0.000 description 2
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 2
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 2
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 2
- BOJYMMBYBNOOGG-DCAQKATOSA-N Lys-Pro-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O BOJYMMBYBNOOGG-DCAQKATOSA-N 0.000 description 2
- OBZHNHBAAVEWKI-DCAQKATOSA-N Lys-Pro-Asn Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O OBZHNHBAAVEWKI-DCAQKATOSA-N 0.000 description 2
- BCRQJDMZQUHQSV-STQMWFEESA-N Met-Gly-Tyr Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BCRQJDMZQUHQSV-STQMWFEESA-N 0.000 description 2
- BJPQKNHZHUCQNQ-SRVKXCTJSA-N Met-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)N BJPQKNHZHUCQNQ-SRVKXCTJSA-N 0.000 description 2
- RMLLCGYYVZKKRT-CIUDSAMLSA-N Met-Ser-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O RMLLCGYYVZKKRT-CIUDSAMLSA-N 0.000 description 2
- GWADARYJIJDYRC-XGEHTFHBSA-N Met-Thr-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GWADARYJIJDYRC-XGEHTFHBSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 2
- 241001529627 Novosphingobium sp. P6W Species 0.000 description 2
- BBDSZDHUCPSYAC-QEJZJMRPSA-N Phe-Ala-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BBDSZDHUCPSYAC-QEJZJMRPSA-N 0.000 description 2
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 2
- NPLGQVKZFGJWAI-QWHCGFSZSA-N Phe-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O NPLGQVKZFGJWAI-QWHCGFSZSA-N 0.000 description 2
- VDTYRPWRWRCROL-UFYCRDLUSA-N Phe-Val-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VDTYRPWRWRCROL-UFYCRDLUSA-N 0.000 description 2
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 2
- CLNJSLSHKJECME-BQBZGAKWSA-N Pro-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1 CLNJSLSHKJECME-BQBZGAKWSA-N 0.000 description 2
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 2
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 2
- BBFRBZYKHIKFBX-GMOBBJLQSA-N Pro-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@@H]1CCCN1 BBFRBZYKHIKFBX-GMOBBJLQSA-N 0.000 description 2
- AQGUSRZKDZYGGV-GMOBBJLQSA-N Pro-Ile-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O AQGUSRZKDZYGGV-GMOBBJLQSA-N 0.000 description 2
- WHNJMTHJGCEKGA-ULQDDVLXSA-N Pro-Phe-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O WHNJMTHJGCEKGA-ULQDDVLXSA-N 0.000 description 2
- SVXXJYJCRNKDDE-AVGNSLFASA-N Pro-Pro-His Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1NCCC1)C1=CN=CN1 SVXXJYJCRNKDDE-AVGNSLFASA-N 0.000 description 2
- FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- ZUGXSSFMTXKHJS-ZLUOBGJFSA-N Ser-Ala-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O ZUGXSSFMTXKHJS-ZLUOBGJFSA-N 0.000 description 2
- GHPQVUYZQQGEDA-BIIVOSGPSA-N Ser-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N)C(=O)O GHPQVUYZQQGEDA-BIIVOSGPSA-N 0.000 description 2
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 2
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 2
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 2
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 2
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 2
- PCMZJFMUYWIERL-ZKWXMUAHSA-N Ser-Val-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMZJFMUYWIERL-ZKWXMUAHSA-N 0.000 description 2
- HNDMFDBQXYZSRM-IHRRRGAJSA-N Ser-Val-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HNDMFDBQXYZSRM-IHRRRGAJSA-N 0.000 description 2
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 2
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 2
- KBLYJPQSNGTDIU-LOKLDPHHSA-N Thr-Glu-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O KBLYJPQSNGTDIU-LOKLDPHHSA-N 0.000 description 2
- WPSDXXQRIVKBAY-NKIYYHGXSA-N Thr-His-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O WPSDXXQRIVKBAY-NKIYYHGXSA-N 0.000 description 2
- XIHGJKFSIDTDKV-LYARXQMPSA-N Thr-Phe-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O XIHGJKFSIDTDKV-LYARXQMPSA-N 0.000 description 2
- NQQMWWVVGIXUOX-SVSWQMSJSA-N Thr-Ser-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NQQMWWVVGIXUOX-SVSWQMSJSA-N 0.000 description 2
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 2
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 2
- XGFYGMKZKFRGAI-RCWTZXSCSA-N Thr-Val-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XGFYGMKZKFRGAI-RCWTZXSCSA-N 0.000 description 2
- HYVLNORXQGKONN-NUTKFTJISA-N Trp-Ala-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 HYVLNORXQGKONN-NUTKFTJISA-N 0.000 description 2
- WLQRIHCMPFHGKP-PMVMPFDFSA-N Trp-Leu-Phe Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)CC(C)C)C(O)=O)C1=CC=CC=C1 WLQRIHCMPFHGKP-PMVMPFDFSA-N 0.000 description 2
- NXRGXTBPMOGFID-CFMVVWHZSA-N Tyr-Ile-Asn Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O NXRGXTBPMOGFID-CFMVVWHZSA-N 0.000 description 2
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 2
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 2
- ISERLACIZUGCDX-ZKWXMUAHSA-N Val-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N ISERLACIZUGCDX-ZKWXMUAHSA-N 0.000 description 2
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 2
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 2
- YTPLVNUZZOBFFC-SCZZXKLOSA-N Val-Gly-Pro Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@@H]1C(O)=O YTPLVNUZZOBFFC-SCZZXKLOSA-N 0.000 description 2
- FTKXYXACXYOHND-XUXIUFHCSA-N Val-Ile-Leu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O FTKXYXACXYOHND-XUXIUFHCSA-N 0.000 description 2
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 2
- RFKJNTRMXGCKFE-FHWLQOOXSA-N Val-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC(C)C)C(O)=O)=CNC2=C1 RFKJNTRMXGCKFE-FHWLQOOXSA-N 0.000 description 2
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 2
- MNSSBIHFEUUXNW-RCWTZXSCSA-N Val-Thr-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N MNSSBIHFEUUXNW-RCWTZXSCSA-N 0.000 description 2
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 2
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 2
- PFMSJVIPEZMKSC-DZKIICNBSA-N Val-Tyr-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N PFMSJVIPEZMKSC-DZKIICNBSA-N 0.000 description 2
- ZNGPROMGGGFOAA-JYJNAYRXSA-N Val-Tyr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 ZNGPROMGGGFOAA-JYJNAYRXSA-N 0.000 description 2
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 2
- 108010062796 arginyllysine Proteins 0.000 description 2
- 108010060035 arginylproline Proteins 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 2
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 2
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 2
- 108010019832 glycyl-asparaginyl-glycine Proteins 0.000 description 2
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 2
- 108010033719 glycyl-histidyl-glycine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 108010084389 glycyltryptophan Proteins 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 108010038745 tryptophylglycine Proteins 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 1
- QADCTXFNLZBZAB-GHCJXIJMSA-N Ile-Asn-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N QADCTXFNLZBZAB-GHCJXIJMSA-N 0.000 description 1
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 1
- GJOBRAHDRIDAPT-NGTWOADLSA-N Thr-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H]([C@@H](C)O)N GJOBRAHDRIDAPT-NGTWOADLSA-N 0.000 description 1
- NDLHSJWPCXKOGG-VLCNGCBASA-N Thr-Trp-Tyr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N)O NDLHSJWPCXKOGG-VLCNGCBASA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 108010077245 asparaginyl-proline Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000004665 defense response Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a preparation method of a glucan oligosaccharide, wherein the glucan oligosaccharide is beta-1, 3-glucan oligosaccharide, the glucan oligosaccharide is prepared by hydrolyzing curdlan with beta-glucanase in one step, and the sequence of the beta-glucanase is shown as SEQ ID NO. 1. The invention obtains a beta-glucanase mutant with improved activity by error-prone PCR screening, and the sequence of the mutant is shown as SEQ ID NO. 2. The hydrolysis rate of the beta-glucanase mutant is higher than 80%, and the polymerization degree of a hydrolysate is 5-7. The method has the advantages of high efficiency, mild reaction, low energy consumption, low cost, no pollution and the like, and can realize the industrial preparation of the beta-1, 3-glucan oligosaccharide.
Description
Technical Field
The invention relates to the technical field of bioengineering, relates to a preparation method of a glucan oligosaccharide, and particularly designs a method for preparing beta-1, 3-glucan oligosaccharide by degrading curdlan with a biological enzyme method.
Background
Curdlan is one of β -glucans, which are secreted mainly by microorganisms. Must be glued byThe D-glucose is connected by beta- (1,3) -glycosidic bond, has no branched chain, and has a molecular weight of 4.4 × 104~1×105. Curdlan has a triple helix structure, is insoluble in most organic reagents such as water and ethanol, and can be dissolved in a solution with hydrogen bond breaking ability, such as a strong alkaline solution with pH > 12, formic acid, dimethyl sulfoxide (DMSO), and the like. Meanwhile, the gel has the characteristic of cooling gel after heating. Furthermore, curdlan powder is often used in the food industry as a food additive, in combination with its colorless and odorless properties. In contrast, beta-1, 3-glucan oligosaccharides have better biological activity, such as inducing plant to generate defense response, immunological activity and the like.
At present, the method for preparing beta-1, 3-glucan oligosaccharides based on hydrolysis curdlan mainly comprises acid hydrolysis. However, the acid hydrolysis efficiency is low, the hydrolysis efficiency is only about 25%, and the polymerization degree span of the product is large; meanwhile, the problems of environmental pollution and the like are caused. The biological hydrolysis of curdlan to prepare beta-1, 3-glucan oligosaccharide is one of the effective, green and pollution-free methods. Research shows that commercial alpha-amylase can hydrolyze curdlan to prepare beta-1, 3-glucan oligosaccharide with the polymerization degree of 1-9, however, the wide polymerization degree of a hydrolysate causes great difficulty for subsequent separation and purification. Therefore, the construction of an efficient hydrolysis process with a narrow polymerization degree is very important for the application of beta-1, 3-glucan oligosaccharide from curdlan.
Disclosure of Invention
The invention aims to provide a method for preparing beta-1, 3-glucan oligosaccharide with narrow polymerization degree by high-efficiency enzymolysis of curdlan. A new beta-glucanase which can hydrolyze curdlan is adopted, and after mutation, the beta-glucanase which can efficiently degrade curdlan is obtained, the hydrolysis efficiency is 80-85%, and the polymerization degree of beta-1, 3-oligoglucan is 5-7.
In order to achieve the purpose, the invention adopts the following technical scheme:
a preparation method of a glucan oligosaccharide takes curdlan as a raw material, and the glucan oligosaccharide is prepared by carrying out enzymolysis on the curdlan through beta-glucanase.
The said oligose is beta-1, 3-oligose with polymerization degree of 5-7.
The reaction conditions of the beta-glucanase are as follows: 1-8mL of curdlan at 1-30g/L, 1-4mL of 1MPBS (pH 5.0-7.0), 0.01-2mL of 0.1-5g/L of beta-glucanase, and deionized water is added into the reaction system at 10 mL. The reaction solution is put in a water bath kettle at the temperature of 30-70 ℃ for reaction for 1-24 h. The hydrolysis rate was measured at 45% -50% after the reaction was completed.
Further preferably, the reaction temperature is 20 to 40 ℃, more preferably, the reaction temperature is 40 ℃.
The PBS solution is preferably pH 6.0;
further preferably, the reaction time is from 1 to 12 h.
The beta-glucanase is derived from Novosphingobium sp.P6W, the amino acid sequence is shown as SEQ ID NO.1, and the nucleotide sequence is shown as SEQ ID NO. 3.
The invention takes the beta-glucanase from Novosphingobium sp.P6W as a template, and carries out non-directed evolution on the sequence of the beta-glucanase to obtain the novel recombinant beta-glucanase, wherein the amino acid sequence of the beta-glucanase is shown as SEQ ID NO. 2. The reaction is faster after mutation, the reaction time is shorter, and the hydrolysis efficiency is higher.
The beta-glucanase mutant (SEQ ID NO.2) is obtained by replacing proline at position 112, leucine at position 300 and isoleucine at position 415 of an original beta-glucanase amino acid sequence shown in SEQ ID NO.1 with glycine, glutamic acid and tyrosine.
The amino acid sequence of the mutant of the beta-glucanase is shown as SEQ ID NO. 2.
A nucleotide sequence of a mutant of beta-glucanase shown in SEQ ID NO. 2.
An expression vector comprising the gene for the beta-glucanase or beta-glucanase mutant.
A recombinant bacterium obtained by transforming a host cell with the above expression vector.
The reaction conditions of the beta-glucanase mutant are as follows: 1-8mL of curdlan at 1-30g/L, 1-4mL of 1M PBS (pH 6.0-8.0), 0.01-2mL of 0.5g/L of beta-glucanase, and deionized water is added into the reaction system at 10 mL. The reaction solution is put in a water bath kettle at the temperature of 30-70 ℃ for reaction for 1-24 h. The hydrolysis rate was determined to be 80% -85% after the reaction was complete.
Preferably, the curdlan concentration is 20g/L, the beta-glucanase solution concentration is 0.5g/L, and the PBS is preferably pH 7.0.
Further preferably, the reaction temperature is 30 to 60 deg.C, more preferably, the reaction temperature is 40 to 50 deg.C.
Further preferably, the reaction time is 1-12 h; more preferably, the reaction time of the beta-glucanase mutant is 1-4 h.
In the invention, the beta-glucanase and the mutant thereof can efficiently carry out enzymolysis on curdlan to prepare beta-1, 3-glucan oligosaccharide with narrow polymerization degree (5-7), the separation of sugar is difficult in industry, and tens of millions of simulated fluid bed devices are usually needed, so the more complex the components of hydrolysate, the larger the polymerization degree span, the more unfavorable the subsequent separation and purification of products, the narrow the polymerization degree of the beta-1, 3-glucan oligosaccharide obtained by the enzymolysis of the invention, and the difficulty of the subsequent separation and purification is greatly reduced.
It is to be noted that the "beta-glucanase gene" also includes a mutated form of SEQ ID No.3 encoding a protein having the same function as the beta-glucanase, said mutated form including: true, nonsense, insert, missense. One skilled in the art will appreciate that as a result of the degeneracy of the genetic code, many different polynucleotides are capable of encoding the same polypeptide. In addition, it will be appreciated that those skilled in the art are able to make nucleotide substitutions using conventional techniques, which substitutions do not affect the polypeptide sequence encoded by the polynucleotide used in the present invention. In addition, the polynucleotides may be modified using methods known in the art to enhance the activity or survival of the polynucleotides of the invention in vivo.
The nucleotide sequence and functional equivalents of the beta-glucanase provided by the invention can be self-adjusted by the skilled person according to the amino acids of the beta-glucanase, the degeneracy principle of the codon and the like, and the adjusted sequences are also within the protection scope of the invention.
Has the advantages that: the invention provides a method for preparing beta-1, 3-glucan oligosaccharide with the polymerization degree of 5-7 by degrading curdlan efficiently and greenly, and the hydrolysis rate is high.
Drawings
FIG. 1 determination of the hydrolysis rate of the wild-type beta-glucanase;
FIG. 2 shows the hydrolysate distribution of curdlan hydrolyzed by wild-type beta-glucanase;
FIG. 3 determination of the enzyme activities of wild type and mutant;
FIG. 4 pH optimum assay for beta-glucanase;
FIG. 5 temperature optima determination of beta-glucanase;
FIG. 6 determination of hydrolysis rate of beta-glucanase mutants;
FIG. 7 shows the hydrolysate distribution of beta-glucanase mutants in hydrolysis of curdlan.
Detailed Description
In order to make the objects, features and advantages of the present invention more obvious and understandable, the technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the embodiments described below are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments that can be derived by one skilled in the art from the embodiments given herein are intended to be within the scope of the invention.
In the following embodiments, the method for preparing curdlan is as follows: 20g of curdlan was dissolved in 1L of 1M NaOH solution and then dissolved by magnetic stirring overnight. The pH was then adjusted to 7 using 1M HCl and the precipitate was collected by centrifugation (6000g,20 min). After washing the precipitate three times with pure water, pure water was added thereto so that the curdlan final concentration was 20g/L, followed by homogenization to prepare a curdlan suspension.
Example 1 preparation of beta-glucanase and use thereof
The gene (sequence shown in SEQ ID NO. 3) of the beta-glucanase is synthesized by general biology (Anhui) GmbH, and the synthesized fragment is constructed into a pET-28a (+) vector (enzyme cutting sites are BamH I and EcoR I). Then it was transformed into E.coli BL21(DE3), and the resulting recombinant strain was cultured in LB medium (NaCl 1%, peptone 1%, yeast powder 0.5%) at 37 ℃ under conditions ofCulturing at 200rpm for 2-3 hours until OD600Adding IPTG with the final concentration of 1mM for induction expression between 0.6 and 0.8, wherein the conditions for induction expression are as follows: further culturing at 30 ℃ and 200rpm for 16 hours, homogenizing and crushing under high pressure, centrifuging at low temperature, and collecting supernatant to obtain the crude enzyme solution of the beta-glucanase.
The beta-glucanase crude enzyme liquid is purified by a high affinity Ni-NTA purification medium (purchased from Nanjing Jinslei Biotech Co., Ltd.), filtered by a dialysis bag and freeze-dried to obtain beta-glucanase powder.
The beta-glucanase powder is subjected to constant volume to 0.5g/L by deionized water, and the enzymolysis reaction is carried out according to the following system: 2.5mL of curdlan at 20g/L, 2mL of 1M citrate buffer (pH 5.0), 0.1mL of 0.5g/L of beta-glucanase, and an additional 5.4mL of water. The reaction solution is placed in a water bath kettle at 40 ℃ for reaction for 16 h. Samples were taken every two hours (20mL) to determine the curdlan content, and the oligosaccharide composition and conversion at the end of the reaction.
The content determination method of curdlan comprises the following steps: boiling 10mL of sample for 5min, centrifuging at high speed (20000g,20min), collecting precipitate, oven drying to heavy weight, weighing and recording mass as m1. In addition, 10mL of 0.5g/L beta-glucanase solution was boiled for 5min, followed by high speed centrifugation (20000g,20min), the precipitate was collected and dried to constant weight, and the recorded mass was weighed as m2。
Content (%) of curdlan ═ m1-m2)/10×100
Wherein, the method for measuring the composition of the oligosaccharide comprises the following steps: and (3) analyzing the polymerization degree of the enzymolysis oligosaccharide component by using the chitosan oligosaccharide with the polymerization degree of 2-10 as a standard substance by adopting HPLC. The chromatographic column is Shodex polyvinyl alcohol amino column (NH)2P-504E), the detector is an evaporative light detector, the mobile phase is acetonitrile/water (0-15 min: 70% -60% acetonitrile; 15-25 min: 60% -50%; acetonitrile; 25-30 min: 50% -70% acetonitrile), flow rate of 1mL/min, column temperature of 30 ℃.
The results are shown in figures 1 and 2, and the enzyme is stable after 12h of enzymolysis, the hydrolysis rate is 47.7%, and the oligosaccharide consists of glucan 5, glucan 6 and glucan 7.
Example 2 screening of beta-glucanase mutants
The objective fragments were randomly mutated using the GeneMorph II Random Mutagenesis Kit (Agilent, USA). Among the primers used were GF (5'-cagcaaatgggtcgcggatccGTGACGTCCCCCGATTTCGGC-3') and GR (5'-ttgtcgacggagctcgaattcTCAGTTGCCGTCCGGCCACGCC-3'). The error-prone PCR system is: mu.L of recombinant plasmid, 1. mu.L each of primers GF and GR, 1. mu.L of Mutazyme II DNA polymerase, 1. mu.L of dNTPs, 5. mu.L of 10 XMutazyme II reaction buffer, made up to 50. mu.L with ddH 2O. The error-prone PCR reaction conditions were: 3min at 95 ℃; 30s at 95 ℃, 30s at 55 ℃ and 1.8min at 72 ℃ (30 cycles); 5min at 72 ℃. Subsequently, after recovery through the column, the plasmid was ligated to pET-28a (+) digested by BamH I and EcoR I by In-fusion cloning to obtain a recombinant plasmid. The recombinant plasmid was transformed into E.coli BL21(DE3) and screened using kanamycin-containing resistant plates.
All transformants were picked into a 96-deep well plate (1mL LB), cultured at 37 ℃ for 2 hours at 200rpm, then induced to express with 0.1M IPTG, and subsequently cultured for 8 hours at 37 ℃ for 200 rpm. 100 μ L of the broth was added to a common 96-well plate and 50mL of 10mM p-nitrophenyl- β -D-glucopyranoside (pNPG), 50mL of 0.2M citrate buffer (pH 5.0) was added. After 10min of reaction, the reaction was terminated by immediately adding a 2% trisodium phosphate solution (pH 12), and the absorption wavelength at 400nm was measured. And (3) taking pNPG solutions with different concentrations as standard curves, and calculating the pNPG content in the reaction solution. Wherein the definition of enzyme activity is as follows: the amount of enzyme required to hydrolyze 1. mu.M pNPG substrate at pH 5 and 40 ℃ per minute.
Relative enzyme activity (%) ═ beta-glucanase mutant enzyme activity multiplied by 100/beta-glucanase initial enzyme activity
The optimum pH test method comprises the following steps of putting 100 mu L of bacteria liquid for induced expression into a common 96-well plate, and additionally adding 50mL of 10mM p-nitrobenzene-beta-D-glucopyranoside (pNPG) and 50mL of 0.2M citrate or phosphate buffer to adjust the pH to 4, 5, 6, 7, 8, 9 and 10; after reacting for 10min at 30 ℃, measuring and calculating the enzyme activity.
The optimum temperature test method comprises the following steps of putting 100 mu L of bacteria liquid for induced expression into a common 96-well plate, and additionally adding 50mL of 10mM p-nitrobenzene-beta-D-glucopyranoside (pNPG) and 50mL of 0.2M citrate buffer (pH 6.0); after reaction at 20, 30, 40, 50, 60, 70 and 80 ℃ for 10min, the enzyme activity was measured and calculated.
The experimental results are shown in figure 3, and the enzyme activities of the mutants 1-63, the mutants 3-75 and the mutants 6-22 are obviously improved. The enzyme activity of the mutant 3-75 is improved most remarkably and is 272% of the initial enzyme activity of the beta-glucanase. Through the study on the optimum pH and the optimum temperature of the mutant 3-75, the mutant is found to be remarkably improved compared with the initial beta-glucanase (figure 4 and figure 5).
Example 3 preparation and use of beta-glucanase mutants
After overnight culture of mutants 3-75, the plasmids of mutants 3-75 were extracted using the Fastpure Plasmid Mini Kit (SoftNavovisa Biotech Co., Ltd., Nanjing) and sent to general-purpose organisms (Anhui) Co., Ltd., where the translated amino acid sequence was shown in SEQ ID NO. 2. Through comparison, the amino acid sequence shown in SEQ ID NO.1 of the original beta-glucanase shown in SEQ ID NO.2 has the proline at position 112 replaced by glycine, the leucine at position 300 replaced by glutamic acid, and the isoleucine at position 415 replaced by tyrosine.
And (3) carrying out IPTG induced expression on the mutant 3-75, homogenizing and crushing the mutant at high pressure, centrifuging the homogenate at low temperature, and collecting the supernatant to obtain the crude enzyme solution of the beta-glucanase mutant. Purifying the crude enzyme liquid of the beta-glucanase mutant by a high-affinity Ni-NTA purification medium, filtering by a dialysis bag, and freeze-drying to obtain powder of the beta-glucanase mutant.
The beta-glucanase mutant powder is subjected to constant volume to 0.5g/L by using deionized water, and the enzymolysis reaction is carried out according to the following system: 2.5mL of curdlan at 20g/L, 2mL of 1M phosphate buffer (pH 7.0), 0.1mL of 0.5g/L beta-glucanase, and an additional 5.4mL of water. The reaction solution is placed in a water bath kettle at 50 ℃ for reaction for 8 hours. Samples were taken every two hours (20mL) to determine the curdlan content, and the oligosaccharide composition and conversion at the end of the reaction. Curdlan content and oligosaccharide were determined as described in example 1.
The results of the experiments are shown in fig. 6 and 7, and the enzyme is stable after 4h enzymolysis, the hydrolysis rate is 82.3%, and the oligosaccharide consists of glucan 5, glucan 6 and glucan 7.
Sequence listing
<110> Suzhou Kening polyol Co., Ltd
<120> preparation method of oligosaccharide
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 588
<212> PRT
<213> Artificial synthesis (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 1
Met Thr Ser Pro Asp Phe Gly Pro Asn Val Ile Leu Leu Asp Pro Ser
1 5 10 15
Met Pro Val Asp Arg Ile Asn Glu Thr Leu Gln Arg Val Glu Lys Asp
20 25 30
Ser Asp Pro Trp Ala Lys Ala Arg Thr Ala Ile Tyr Leu Leu Pro Gly
35 40 45
Thr Tyr Gly Lys Pro Ala Ala Gln Asn Ala Gln Lys Ala Ala Ala Gly
50 55 60
Tyr Ile Asn Ser Val Val Gly Pro Met Thr Ser Ile Gln Gly Leu Gly
65 70 75 80
Ala Glu Pro Gly Asp Val Val Val Asn Gly Asn Leu Arg Ile Ile Gly
85 90 95
Asn Leu Gly Thr Phe Trp Arg Ser Leu Gln Asn Met Arg Ile Asn Pro
100 105 110
Ile Asp Pro Glu Ser Pro Gly Ala Leu Arg Trp Ile Val Ser Glu Ala
115 120 125
Ser Pro Leu Arg Arg Ile Asp Ile Ser Gly Asp Leu Asp Leu Gly Val
130 135 140
Gly His Val Ala Phe Gly Ala Ala Ile Gly Asn Thr Arg Val Ser Gly
145 150 155 160
Val Val Asn Ser Gly Asn Gly Arg Ala Lys Asp Val Pro Gly Ala Gly
165 170 175
Gly Gln Ala His Tyr Tyr Ala Gln Asn Ser Val Phe Lys Gly Gly Trp
180 185 190
Ile Gly Gln Ser Val Asn Phe Val Phe Ser Gly Val Gln Gly Ala Pro
195 200 205
Pro Thr Asp Phe Gly Pro Arg Ala Gly Lys Asp Gly Pro Gly Asp Lys
210 215 220
Thr Thr Leu Gly Thr Thr Pro Val Ser Arg Asp Ala Pro Phe Leu Phe
225 230 235 240
Val Asp Arg Gly Arg Tyr Ser Val Phe Val Pro Lys Ala Arg Met Asn
245 250 255
Ala Arg Gly Ile Ala Trp Gly Leu Gly Lys Pro Asn Gly Asp Val Gln
260 265 270
Pro Ile Asn Ala Tyr Phe Ile Ala Lys Pro Thr Asp Asn Ala Ala Thr
275 280 285
Ile Asn Ala Ala Leu Ala Gly Gly Lys Asn Leu Leu Leu Thr Pro Gly
290 295 300
Val Tyr Glu Leu Asp Ala Pro Ile Asp Val Thr Arg Pro Gly Thr Val
305 310 315 320
Val Leu Gly Met Gly Tyr Ala Thr Leu Gln Pro Val Arg Gly Thr Ser
325 330 335
Ala Leu Arg Ile Gly Asp Val Pro Gly Val Val Val Ser Ser Leu Val
340 345 350
Val Asp Ala Gly Leu Leu Asn Ser Asp Val Leu Ile Glu Val Gly Pro
355 360 365
Lys Gly Ala Asn His Gly Ser Ala Ala Asn Pro Thr Ser Leu Val Asp
370 375 380
Val Tyr Val Arg Val Gly Thr Asp Ile Ser Gly Lys Ala Thr Thr Ser
385 390 395 400
Val Glu Ile Asn Gln Asn His Ala Leu Ile Asn His Thr Trp Ile Trp
405 410 415
Arg Gly Asp Leu Ser Pro Gly Ala Lys Gly Trp Glu Thr Asn Ala Gly
420 425 430
Asp Val Gly Leu Val Val Asn Gly Asp Asn Val Thr Val Leu Gly Ala
435 440 445
Tyr Val Glu His Tyr Arg Lys Gln Gln Val Leu Trp Asn Gly Asp Gly
450 455 460
Gly Arg Thr Ile Phe Phe Gln Ser Glu Pro Pro His Asp Ala Leu Thr
465 470 475 480
Gln Ser Asp Arg Met Asn Gly Thr Glu Lys Gly Tyr Ala Tyr Tyr Glu
485 490 495
Leu Ala Pro Thr Val Arg Thr His Glu Gly Ile Gly Phe Ala Leu Tyr
500 505 510
Gly Ala Ala Ser Lys Ser Thr Glu Pro Ile Ile Gln Met Ser Glu Ile
515 520 525
Lys Ala Pro Glu Arg Pro Gly Ile Ser Phe Arg Ser Val Thr Gly Val
530 535 540
Trp Leu Phe Gly His Gly Gln Tyr Leu Asn Thr Phe Asn Ser Asp Gly
545 550 555 560
Arg Ala Val Gly Lys Asp Ile Val Pro Ser Phe Val Pro Gly Ile Ala
565 570 575
Ala Thr Arg Gln Val Val Ala Trp Pro Asp Gly Asn
580 585
<210> 2
<211> 588
<212> PRT
<213> Artificial synthesis (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 2
Met Thr Ser Pro Asp Phe Gly Pro Asn Val Ile Leu Leu Asp Pro Ser
1 5 10 15
Met Pro Val Asp Arg Ile Asn Glu Thr Leu Gln Arg Val Glu Lys Asp
20 25 30
Ser Asp Pro Trp Ala Lys Ala Arg Thr Ala Ile Tyr Leu Leu Pro Gly
35 40 45
Thr Tyr Gly Lys Pro Ala Ala Gln Asn Ala Gln Lys Ala Ala Ala Gly
50 55 60
Tyr Ile Asn Ser Val Val Gly Pro Met Thr Ser Ile Gln Gly Leu Gly
65 70 75 80
Ala Glu Pro Gly Asp Val Val Val Asn Gly Asn Leu Arg Ile Ile Gly
85 90 95
Asn Leu Gly Thr Phe Trp Arg Ser Leu Gln Asn Met Arg Ile Asn Gly
100 105 110
Ile Asp Pro Glu Ser Pro Gly Ala Leu Arg Trp Ile Val Ser Glu Ala
115 120 125
Ser Pro Leu Arg Arg Ile Asp Ile Ser Gly Asp Leu Asp Leu Gly Val
130 135 140
Gly His Val Ala Phe Gly Ala Ala Ile Gly Asn Thr Arg Val Ser Gly
145 150 155 160
Val Val Asn Ser Gly Asn Gly Arg Ala Lys Asp Val Pro Gly Ala Gly
165 170 175
Gly Gln Ala His Tyr Tyr Ala Gln Asn Ser Val Phe Lys Gly Gly Trp
180 185 190
Ile Gly Gln Ser Val Asn Phe Val Phe Ser Gly Val Gln Gly Ala Pro
195 200 205
Pro Thr Asp Phe Gly Pro Arg Ala Gly Lys Asp Gly Pro Gly Asp Lys
210 215 220
Thr Thr Leu Gly Thr Thr Pro Val Ser Arg Asp Ala Pro Phe Leu Phe
225 230 235 240
Val Asp Arg Gly Arg Tyr Ser Val Phe Val Pro Lys Ala Arg Met Asn
245 250 255
Ala Arg Gly Ile Ala Trp Gly Leu Gly Lys Pro Asn Gly Asp Val Gln
260 265 270
Pro Ile Asn Ala Tyr Phe Ile Ala Lys Pro Thr Asp Asn Ala Ala Thr
275 280 285
Ile Asn Ala Ala Leu Ala Gly Gly Lys Asn Leu Glu Leu Thr Pro Gly
290 295 300
Val Tyr Glu Leu Asp Ala Pro Ile Asp Val Thr Arg Pro Gly Thr Val
305 310 315 320
Val Leu Gly Met Gly Tyr Ala Thr Leu Gln Pro Val Arg Gly Thr Ser
325 330 335
Ala Leu Arg Ile Gly Asp Val Pro Gly Val Val Val Ser Ser Leu Val
340 345 350
Val Asp Ala Gly Leu Leu Asn Ser Asp Val Leu Ile Glu Val Gly Pro
355 360 365
Lys Gly Ala Asn His Gly Ser Ala Ala Asn Pro Thr Ser Leu Val Asp
370 375 380
Val Tyr Val Arg Val Gly Thr Asp Ile Ser Gly Lys Ala Thr Thr Ser
385 390 395 400
Val Glu Ile Asn Gln Asn His Ala Leu Ile Asn His Thr Trp Tyr Trp
405 410 415
Arg Gly Asp Leu Ser Pro Gly Ala Lys Gly Trp Glu Thr Asn Ala Gly
420 425 430
Asp Val Gly Leu Val Val Asn Gly Asp Asn Val Thr Val Leu Gly Ala
435 440 445
Tyr Val Glu His Tyr Arg Lys Gln Gln Val Leu Trp Asn Gly Asp Gly
450 455 460
Gly Arg Thr Ile Phe Phe Gln Ser Glu Pro Pro His Asp Ala Leu Thr
465 470 475 480
Gln Ser Asp Arg Met Asn Gly Thr Glu Lys Gly Tyr Ala Tyr Tyr Glu
485 490 495
Leu Ala Pro Thr Val Arg Thr His Glu Gly Ile Gly Phe Ala Leu Tyr
500 505 510
Gly Ala Ala Ser Lys Ser Thr Glu Pro Ile Ile Gln Met Ser Glu Ile
515 520 525
Lys Ala Pro Glu Arg Pro Gly Ile Ser Phe Arg Ser Val Thr Gly Val
530 535 540
Trp Leu Phe Gly His Gly Gln Tyr Leu Asn Thr Phe Asn Ser Asp Gly
545 550 555 560
Arg Ala Val Gly Lys Asp Ile Val Pro Ser Phe Val Pro Gly Ile Ala
565 570 575
Ala Thr Arg Gln Val Val Ala Trp Pro Asp Gly Asn
580 585
<210> 3
<211> 1767
<212> DNA
<213> Artificial synthesis (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 3
gtgacgtccc ccgatttcgg cccgaacgtg atcctgctcg atccatccat gccggtcgat 60
cgcatcaacg aaaccttgca gcgtgtcgaa aaggattcgg atccctgggc aaaagcgcgc 120
accgcgatct atctgctgcc gggaacctat ggaaagcctg cggcccaaaa tgcgcaaaag 180
gccgcggcgg gctacatcaa ctcggtcgtc gggccgatga cgtcgattca ggggctcggc 240
gctgagcccg gcgatgtcgt cgtcaacggc aacctgcgca tcatcggcaa cctcggcacg 300
ttctggcgga gcctgcagaa catgcggatc aatccgatcg atccggagtc accgggcgcg 360
ctgcgctgga tcgtctcgga ggcctcgccg ctgcgccgga tcgatatctc gggcgacctc 420
gatcttggcg tgggccatgt cgccttcggc gccgcgatcg gaaacacgcg agtatcgggg 480
gtcgtcaatt ccggcaacgg acgggcaaag gacgttccgg gcgcgggcgg gcaggcgcat 540
tattatgcgc agaacagcgt ctttaagggc ggctggatcg ggcagtcggt caatttcgtg 600
ttctccggcg tgcaaggtgc gccgccgacc gacttcggcc cccgcgccgg caaagacggg 660
ccgggtgaca agaccacgct gggcacgacg ccggtatccc gggacgcccc gttcctcttc 720
gtcgatcgtg gccgctacag cgtgttcgtc ccgaaggcgc gaatgaacgc gcgcggcatc 780
gcttggggat tgggaaagcc gaatggcgac gttcagccga tcaacgcata tttcatcgcc 840
aagccgaccg ataacgctgc gacgatcaac gccgccctgg ccggtggcaa gaacctgctg 900
ctgacaccgg gcgtgtacga gctggatgca cccatcgacg tcacccgtcc cggcaccgtt 960
gttctcggca tgggatatgc gacgctgcaa ccggttcgcg gcacgtccgc gctacggatc 1020
ggcgacgtac ccggagtcgt ggtgtcttcg ctcgtcgtgg atgcggggct gctgaactcc 1080
gatgtgctca tcgaggttgg gccaaagggg gccaaccatg ggtcggcggc caatccgacg 1140
tccttggtcg acgtctatgt tcgcgtcgga acggacattt cgggcaaggc gaccaccagt 1200
gtcgaaatca accagaacca cgcgctcatc aatcatacat ggatctggcg cggggacctt 1260
tcaccaggcg cgaaaggctg ggaaacgaat gcaggcgacg tcgggctggt ggtcaatgga 1320
gacaacgtca ccgttctcgg cgcgtatgtc gagcattacc gcaagcaaca ggtgctctgg 1380
aacggcgacg gcggccggac gatctttttc caatcagagc ctccccatga cgcgctgacc 1440
caatcggacc gcatgaacgg caccgaaaag ggctatgcat attacgagct cgcgccgacc 1500
gttcgaacgc acgagggcat cggcttcgct ctgtacggcg ccgcgagcaa gtcgaccgaa 1560
ccgatcatcc agatgagtga gatcaaggct cccgagcggc ccggcatttc attccgcagc 1620
gtcacaggag tatggctgtt cggtcacggc cagtatctga ataccttcaa ttccgatggg 1680
cgcgccgtcg gtaaggacat cgttccaagc ttcgtgccgg gcatcgcggc gacacggcag 1740
gtcgtggcgt ggccggacgg caactga 1767
<210> 4
<211> 42
<212> DNA
<213> Artificial synthesis (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 4
cagcaaatgg gtcgcggatc cgtgacgtcc cccgatttcg gc 42
<210> 5
<211> 43
<212> DNA
<213> Artificial synthesis (2 Ambystoma latex x Ambystoma jeffersonia)
<400> 5
ttgtcgacgg agctcgaatt ctcagttgcc gtccggccac gcc 43
Claims (9)
1. A preparation method of a glucan oligosaccharide is characterized in that curdlan is used as a raw material, and the glucan oligosaccharide is prepared by carrying out enzymolysis on curdlan through beta-glucanase; the beta-glucanase is beta-glucanase with an amino acid sequence shown as SEQ ID NO.1 and a mutant thereof.
2. The method for preparing a glucan oligosaccharide according to claim 1, wherein the glucan oligosaccharide is a β -1, 3-glucan oligosaccharide, and the degree of polymerization is 5-7.
3. The method of claim 1, wherein the beta-glucanase is derived fromNovosphingobium sp. P6W。
4. The method of claim 1, wherein the beta-glucanase mutant has a substitution of proline at position 112, a substitution of leucine at position 300 with glutamic acid, and a substitution of isoleucine at position 415 with tyrosine, of the beta-glucanase represented by SEQ ID NO. 1.
5. The method of claim 1, wherein the curdlan and the beta-glucanase are used in a ratio of 50-5000:1 (w/w).
6. The method for preparing the oligo-saccharide according to claim 1, wherein the enzymatic reaction is carried out at 30-70 ℃ for 1-24 h.
7. The method for preparing glucan oligosaccharide according to claim 1, wherein the curdlan concentration is 1-30g/L, and the beta-glucanase solution concentration is 0.1-5 g/L.
8. A mutant β -glucanase characterized in that proline at position 112, leucine at position 300, and isoleucine at position 415 of the β -glucanase represented by SEQ ID NO.1 are replaced with glycine, glutamic acid, and tyrosine, respectively.
9. The beta-glucanase mutant according to claim 8, characterized in that the sequence of the beta-glucanase mutant is shown in SEQ ID No. 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111636211.0A CN114317636B (en) | 2021-12-29 | 2021-12-29 | Preparation method of oligose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111636211.0A CN114317636B (en) | 2021-12-29 | 2021-12-29 | Preparation method of oligose |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114317636A true CN114317636A (en) | 2022-04-12 |
CN114317636B CN114317636B (en) | 2022-12-23 |
Family
ID=81016408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111636211.0A Active CN114317636B (en) | 2021-12-29 | 2021-12-29 | Preparation method of oligose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114317636B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003164284A (en) * | 2001-11-30 | 2003-06-10 | Noda Inst For Scient Res | New endoglucanase and endoglucanase gene |
CN105431534A (en) * | 2013-08-02 | 2016-03-23 | 优瑞纳股份有限公司 | beta-1,3-glucanase, polynucleotide, recombinant vector, transformant, production method for beta-1,3-glucanase, enzyme preparation, and production method for paramylon having reduced molecular weight |
CN106085989A (en) * | 2016-06-14 | 2016-11-09 | 中国农业大学 | One Bacillus species β 1,3 1,4 glucanase and encoding gene thereof and application |
CN110036108A (en) * | 2016-11-09 | 2019-07-19 | 中国农业大学 | A kind of bacterium beta-1,3-glucanase and its encoding gene and application |
-
2021
- 2021-12-29 CN CN202111636211.0A patent/CN114317636B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003164284A (en) * | 2001-11-30 | 2003-06-10 | Noda Inst For Scient Res | New endoglucanase and endoglucanase gene |
CN105431534A (en) * | 2013-08-02 | 2016-03-23 | 优瑞纳股份有限公司 | beta-1,3-glucanase, polynucleotide, recombinant vector, transformant, production method for beta-1,3-glucanase, enzyme preparation, and production method for paramylon having reduced molecular weight |
CN106085989A (en) * | 2016-06-14 | 2016-11-09 | 中国农业大学 | One Bacillus species β 1,3 1,4 glucanase and encoding gene thereof and application |
CN110036108A (en) * | 2016-11-09 | 2019-07-19 | 中国农业大学 | A kind of bacterium beta-1,3-glucanase and its encoding gene and application |
Non-Patent Citations (1)
Title |
---|
NIKOLAICHIK,Y.A.等: "AXB80501.1,adenylyl cyclase(plasmid) [Novosphingobium sp.P6W]", 《NCBI GEBANK》 * |
Also Published As
Publication number | Publication date |
---|---|
CN114317636B (en) | 2022-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101473918B1 (en) | D-psicose 3-epimerase, manufacturing method thereof and manufacturing method of D-psicose using the same | |
CN110438136B (en) | Beta-glucosidase and mutant gene, amino acid sequence and application thereof | |
KR101521711B1 (en) | Novel β-agarooligosaccharide hydrolase and enzymatic production method of 3,6-anhydro-L-galactose and galactose from agarose by using the same | |
WO2017197546A1 (en) | Β-mannanase mrmman5a and encoding gene and application thereof | |
CN112063666B (en) | Application of recombinant sucrose isomerase in preparation of isomaltulose by converting sucrose | |
CN111647579A (en) | Thermolabile exoinulase mutant MutQ23 delta 9 and preparation and application thereof | |
CN112941052B (en) | Chitosanase OUC-T613 and application thereof | |
JP7241368B2 (en) | Ulva polysaccharide lyase and its coding gene and application | |
JP2023506154A (en) | Allulose epimerization enzyme mutant, method for producing the same, and method for producing allulose using the same | |
CN114480350B (en) | Application of carrageenase in degrading kappa-carrageenan and furcellaran | |
CN114015675A (en) | Lambda-carrageenase OUC-LuV and application thereof | |
CN111996205A (en) | Chitinase gene, chitinase and preparation method and application thereof | |
CN114836405B (en) | Agarase mutant with improved thermal stability and application thereof | |
CN110144341B (en) | Alginate lyase mutant | |
CN111621488B (en) | Heat-adaptability-improved inulase exonuclease mutant MutQ23 delta 11 | |
CN113151212A (en) | Dextran sucrase and preparation method and application thereof | |
KR101919105B1 (en) | A Novel alpha-neoagarobiose hydrolase from Gayadomonas joobiniege G7 and use thereof | |
CN114317636B (en) | Preparation method of oligose | |
CN114836406B (en) | Agarase mutant with improved catalytic activity and application thereof | |
CN107779443B (en) | Cellobiohydrolase mutants and uses thereof | |
CN112725315B (en) | Application of chitosanase and mutant thereof in preparation of chitosan oligosaccharide | |
CN110951716B (en) | Circumscribed alginate lyase VsAly7D, recombinant strain thereof and application thereof | |
CN117402857A (en) | High specific activity amylase mutant | |
KR101250828B1 (en) | A chitinase and a use of the same | |
CN113046376A (en) | Mannase gene VbMan26A, recombinant plasmid, recombinant strain, mannase and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 215000, No. 30 Nanguandu Road, Economic Development Zone, Wuzhong District, Suzhou City, Jiangsu Province Patentee after: Suzhou Koning polyol Co.,Ltd. Country or region after: China Address before: 215000 1183 Wuzhong Avenue, economic development zone, Wuzhong District, Suzhou City, Jiangsu Province Patentee before: Suzhou Koning polyol Co.,Ltd. Country or region before: China |